Multiplicom
Universiteit Antwerpen

Multiplicom

Biotech
Biotech
Biotech
Biotech

Acquired by Agilent Technologies

Multiplicom was created in 2011 as a spin-off of the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine.

Acquired by Agilent Technologies.

No items found.

This company is aligned with the following SDGs

No items found.
Aphea.Bio
Qbic II
Biotech
Biotech
Biotech
Biotech

Aphea.Bio

Aphea.Bio is developing the next generation of agricultural biologicals

Universiteit Gent
moveUP
Qbic II
HealthTech
HealthTech
HealthTech
HealthTech

moveUP

moveUP develops personalized remote digital care for patients undergoing surgery and other interventions

AZ Maria Middelares
VUB
Flindr Therapeutics
Qbic III
Biotech
Biotech
Biotech
Biotech

Flindr Therapeutics

Flindr aims to restore a patient’s impaired immune response to cancer

Universiteit Gent